
### [NCIT:C3209](http://purl.obolibrary.org/obo/NCIT_C3209)
**Label:** Follicular Lymphoma

**Subclasses:** [NCIT:C7307](http://purl.obolibrary.org/obo/NCIT_C7307) (Splenic Follicular Lymphoma), [NCIT:C3465](http://purl.obolibrary.org/obo/NCIT_C3465) (Grade 1 Follicular Lymphoma), [NCIT:C8858](http://purl.obolibrary.org/obo/NCIT_C8858) (Refractory Follicular Lymphoma), [NCIT:C6859](http://purl.obolibrary.org/obo/NCIT_C6859) (Grade 3 Cutaneous Follicular Lymphoma), [NCIT:C96056](http://purl.obolibrary.org/obo/NCIT_C96056) (Small Intestinal Follicular Lymphoma), [NCIT:C8859](http://purl.obolibrary.org/obo/NCIT_C8859) (Stage I Follicular Lymphoma), [NCIT:C8119](http://purl.obolibrary.org/obo/NCIT_C8119) (Stage II Grade 3 Follicular Lymphoma), [NCIT:C5006](http://purl.obolibrary.org/obo/NCIT_C5006) (Stage IV Follicular Lymphoma), [NCIT:C8117](http://purl.obolibrary.org/obo/NCIT_C8117) (Stage II Grade 2 Follicular Lymphoma), [NCIT:C5007](http://purl.obolibrary.org/obo/NCIT_C5007) (Recurrent Follicular Lymphoma), [NCIT:C8116](http://purl.obolibrary.org/obo/NCIT_C8116) (Stage II Grade 1 Follicular Lymphoma), [NCIT:C8158](http://purl.obolibrary.org/obo/NCIT_C8158) (Recurrent Grade 3 Follicular Lymphoma), [NCIT:C8155](http://purl.obolibrary.org/obo/NCIT_C8155) (Recurrent Grade 1 Follicular Lymphoma), [NCIT:C9464](http://purl.obolibrary.org/obo/NCIT_C9464) (Grade 1 Diffuse Follicular Lymphoma), [NCIT:C8156](http://purl.obolibrary.org/obo/NCIT_C8156) (Recurrent Grade 2 Follicular Lymphoma), [NCIT:C7264](http://purl.obolibrary.org/obo/NCIT_C7264) (Diffuse Follicular Lymphoma), [NCIT:C3460](http://purl.obolibrary.org/obo/NCIT_C3460) (Grade 3 Follicular Lymphoma), [NCIT:C8132](http://purl.obolibrary.org/obo/NCIT_C8132) (Stage III Grade 3 Follicular Lymphoma), [NCIT:C7220](http://purl.obolibrary.org/obo/NCIT_C7220) (Grade 1 Cutaneous Follicular Lymphoma), [NCIT:C7192](http://purl.obolibrary.org/obo/NCIT_C7192) (Grade 3b Follicular Lymphoma), [NCIT:C7194](http://purl.obolibrary.org/obo/NCIT_C7194) (Grade 2 Diffuse Follicular Lymphoma), [NCIT:C7191](http://purl.obolibrary.org/obo/NCIT_C7191) (Grade 3a Follicular Lymphoma), [NCIT:C7219](http://purl.obolibrary.org/obo/NCIT_C7219) (Grade 2 Cutaneous Follicular Lymphoma), [NCIT:C8968](http://purl.obolibrary.org/obo/NCIT_C8968) (Grade 2 Follicular Lymphoma), [NCIT:C7218](http://purl.obolibrary.org/obo/NCIT_C7218) (Cutaneous Follicular Lymphoma), [NCIT:C80298](http://purl.obolibrary.org/obo/NCIT_C80298) (Primary Intestinal Follicular Lymphoma), [NCIT:C7217](http://purl.obolibrary.org/obo/NCIT_C7217) (Primary Cutaneous Follicle Center Lymphoma), [NCIT:C8129](http://purl.obolibrary.org/obo/NCIT_C8129) (Stage III Grade 1 Follicular Lymphoma), [NCIT:C8861](http://purl.obolibrary.org/obo/NCIT_C8861) (Stage III Follicular Lymphoma), [NCIT:C8145](http://purl.obolibrary.org/obo/NCIT_C8145) (Stage IV Grade 3 Follicular Lymphoma), [NCIT:C138185](http://purl.obolibrary.org/obo/NCIT_C138185) (Duodenal-Type Follicular Lymphoma), [NCIT:C8860](http://purl.obolibrary.org/obo/NCIT_C8860) (Stage II Follicular Lymphoma), [NCIT:C138186](http://purl.obolibrary.org/obo/NCIT_C138186) (Predominantly Diffuse Follicular Lymphoma with 1p36 Deletion), [NCIT:C8142](http://purl.obolibrary.org/obo/NCIT_C8142) (Stage IV Grade 1 Follicular Lymphoma), [NCIT:C8143](http://purl.obolibrary.org/obo/NCIT_C8143) (Stage IV Grade 2 Follicular Lymphoma), [NCIT:C40377](http://purl.obolibrary.org/obo/NCIT_C40377) (Breast Follicular Lymphoma), [NCIT:C8130](http://purl.obolibrary.org/obo/NCIT_C8130) (Stage III Grade 2 Follicular Lymphoma), [NCIT:C8072](http://purl.obolibrary.org/obo/NCIT_C8072) (Stage I Grade 2 Follicular Lymphoma), [NCIT:C8073](http://purl.obolibrary.org/obo/NCIT_C8073) (Stage I Grade 3 Follicular Lymphoma), [NCIT:C8071](http://purl.obolibrary.org/obo/NCIT_C8071) (Stage I Grade 1 Follicular Lymphoma), [NCIT:C80297](http://purl.obolibrary.org/obo/NCIT_C80297) (Pediatric-Type Follicular Lymphoma), [NCIT:C37209](http://purl.obolibrary.org/obo/NCIT_C37209) (Diffuse Blastoid B-Cell Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 55.08%
- [NCIT:C132019](http://purl.obolibrary.org/obo/NCIT_C132019) (BCL2 Gene Rearrangement) and (not ([NCIT:C38176](http://purl.obolibrary.org/obo/NCIT_C38176) (BCL2 Gene Translocation))) 54.00%
- [NCIT:C36452](http://purl.obolibrary.org/obo/NCIT_C36452) (Clonal Immunoglobulin Lambda Light Chain Gene Rearrangement) 52.00%
- [NCIT:C36449](http://purl.obolibrary.org/obo/NCIT_C36449) (Clonal BCL6 Gene Rearrangement) 52.00%
- [NCIT:C36444](http://purl.obolibrary.org/obo/NCIT_C36444) (Clonal Immunoglobulin Heavy Chain Gene Rearrangement) 52.00%
- [NCIT:C36442](http://purl.obolibrary.org/obo/NCIT_C36442) (Clonal BCL2 Gene Rearrangement) 52.00%
- [NCIT:C132019](http://purl.obolibrary.org/obo/NCIT_C132019) (BCL2 Gene Rearrangement) and [NCIT:C36333](http://purl.obolibrary.org/obo/NCIT_C36333) (Clonal Gene Rearrangement) 52.00%
- [NCIT:C132019](http://purl.obolibrary.org/obo/NCIT_C132019) (BCL2 Gene Rearrangement) 44.82%
- [NCIT:C132019](http://purl.obolibrary.org/obo/NCIT_C132019) (BCL2 Gene Rearrangement) and (not ([NCIT:C38331](http://purl.obolibrary.org/obo/NCIT_C38331) (Intraepithelial T-Lymphocyte))) 44.82%
- [NCIT:C132019](http://purl.obolibrary.org/obo/NCIT_C132019) (BCL2 Gene Rearrangement) and (not ([NCIT:C38329](http://purl.obolibrary.org/obo/NCIT_C38329) (Thymic B-Lymphocyte))) 44.82%
- [NCIT:C132019](http://purl.obolibrary.org/obo/NCIT_C132019) (BCL2 Gene Rearrangement) and (not ([NCIT:C38328](http://purl.obolibrary.org/obo/NCIT_C38328) (Unfavorable Clinical Outcome))) 44.82%
- [NCIT:C132019](http://purl.obolibrary.org/obo/NCIT_C132019) (BCL2 Gene Rearrangement) and (not ([NCIT:C38327](http://purl.obolibrary.org/obo/NCIT_C38327) (Immature Peripheral Alpha/Beta Cell of Cytotoxic Type))) 44.82%
- [NCIT:C132019](http://purl.obolibrary.org/obo/NCIT_C132019) (BCL2 Gene Rearrangement) and (not ([NCIT:C38326](http://purl.obolibrary.org/obo/NCIT_C38326) (Immature Peripheral Gamma/Delta Cell of Cytotoxic Type))) 44.82%
- [NCIT:C132019](http://purl.obolibrary.org/obo/NCIT_C132019) (BCL2 Gene Rearrangement) and (not ([NCIT:C38323](http://purl.obolibrary.org/obo/NCIT_C38323) (Peripheral Epidermotropic T-Lymphocyte))) 44.82%
- [NCIT:C132019](http://purl.obolibrary.org/obo/NCIT_C132019) (BCL2 Gene Rearrangement) and (not ([NCIT:C38322](http://purl.obolibrary.org/obo/NCIT_C38322) (Marginal Zone B-Lymphocyte of Nodal Type))) 44.82%


